Business description: Boston Scientific Corporation

Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:

- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);

- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;

- neuromodulation (2%).

The United States account for 59.2% of net sales.

Number of employees: 48,000

Sales by Activity: Boston Scientific Corporation

Fiscal Period: December20192020202120222023

Cardiovascular (Incl. Rhythm)

420.8Cr 387.6Cr 485.8Cr 816.1Cr 863Cr

Med Surg

330.7Cr 306.6Cr 372.4Cr 505.7Cr 532Cr

Rhythm and Neuro

314Cr 275.2Cr 329.3Cr - -

Unallocated Impact of Foreign Currency Fluctuations

- - - -48Cr 29Cr

Other

- - - -6Cr -

Specialty Pharmaceuticals

8.1Cr 22Cr 1.3Cr - -
See all business segments

Geographical breakdown of sales: Boston Scientific Corporation

Fiscal Period: December20192020202120222023

United States (U.S.)

616.7Cr 570.1Cr 691.1Cr 763.2Cr 842.5Cr

Europe, Middle East and Africa (EMEA)

226.4Cr 209.7Cr 251.8Cr 252.6Cr 285.6Cr

Asia-Pacific (APAC)

189.8Cr 178.1Cr 207Cr 211.6Cr 240Cr

Latin America and Canada (LACA)

40Cr 31Cr 39Cr 47Cr 56Cr

International

1.1Cr 2.7Cr 40L - -

Other Countries

- - - -6Cr -
See all geographic segments

Managers: Boston Scientific Corporation

Director TitleAgeSince
Chief Executive Officer 59 01/11/2011
Director of Finance/CFO 58 31/12/2013
Chief Tech/Sci/R&D Officer - 01/09/2009
Chief Tech/Sci/R&D Officer 51 01/07/2020
Chief Operating Officer 56 01/05/2022
See BOSTON SCIENTIFIC CORPORATION governance

Members of the board: Boston Scientific Corporation

Manager TitleAgeSince
Director/Board Member 59 01/04/2009
Chairman 59 03/05/2016
Director/Board Member 72 01/03/2014
Director/Board Member 69 01/04/2015
Director/Board Member 73 15/04/2016
Director/Board Member 72 13/07/2016
Director/Board Member 61 23/06/2021
Director/Board Member 49 27/06/2023
Director/Board Member - 27/06/2023
Director/Board Member 60 08/05/2024
Composition of the Board of Directors

Shareholders: Boston Scientific Corporation

NameEquities%Valuation
Fidelity Management & Research Co. LLC
9.172 %
135,175,033 9.172 % 12 255 M $
Vanguard Fiduciary Trust Co.
8.908 %
131,290,722 8.908 % 11 903 M $
BlackRock Advisors LLC
6.246 %
92,056,623 6.246 % 8 346 M $
62,846,328 4.264 % 5 698 M $
PRIMECAP Management Co.
2.567 %
37,826,500 2.567 % 3 429 M $
NameEquities%Valuation
BRAM - Bradesco Asset Management SA DTVM
0.000235 %
3,459 0.000235 % 312 603 $
XP Allocation Asset Management Ltda.
0.000032 %
472 0.000032 % 42 656 $
List of BOSTON SCIENTIFIC CORPORATION shareholders

Holdings: Boston Scientific Corporation

NameEquities%Valuation
203,702,96265.00%184,552,847 $
3,180,0009.83%18,235,901 $

Company details: Boston Scientific Corporation

Boston Scientific Corp.

300 Boston Scientific Way

01752-1234, Marlborough

+508 683 4000

http://www.bostonscientific.com
address Boston Scientific Corporation(BSX)

Group companies: Boston Scientific Corporation

NameCategory and Sector
Medical Specialties
Boston Scientific Technology & Engineering Services Pvt Ltd.
Hospital/Nursing Management
Medical Specialties
Boston Scientific Benelux NV
Medical Specialties
See all subsidiaries

Other Advanced Medical Equipment & Technology

Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+0.40%-0.34%+63.83%+118.51%13TCr
+0.11%+1.56%+8.51%-16.86%20TCr
+1.44%-0.96%+72.68%+60.03%19TCr
+0.87%+0.24%+6.99%-25.64%17TCr
+0.95%+4.52%+3.48%-18.62%6.29TCr
-0.26%+0.61%-11.39%-29.22%4.39TCr
+0.67%-0.54%+4.96%-38.88%4.33TCr
+0.44%+1.90%+10.78%-8.59%4.05TCr
+0.79%-0.19%+16.48% - 3.76TCr
-0.11%-0.86%+49.03%-7.50%3.6TCr
Average +0.52%+0.96%+22.53%+3.69% 9.63TCr
Weighted average by Cap. +0.64%+0.12%+29.18%+15.90%
See all sector performances
Trading Rating
Investor Rating
ESG Refinitiv
A-
surperformance-ratings-light-chart BOSTON-SCIENTIFIC-CORPORAMore Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
90.20USD
Average target price
97.69USD
Spread / Average Target
+8.30%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. BSX Stock
  4. Company Boston Scientific Corporation